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Chromosomal DNA deletion confers
phage resistance to Pseudomonas
aeruginosa
Shuai Le1,2, Xinyue Yao1, Shuguang Lu1, Yinling Tan1, Xiancai Rao1, Ming Li1, Xiaolin Jin1, Jing Wang1,
Yan Zhao1, Nicholas C. Wu3, Renate Lux2, Xuesong He2, Wenyuan Shi2 & Fuquan Hu1
1Department of Microbiology, Third Military Medical University, Chongqing, 400038, China, 2School of Dentistry, University of
California, Los Angeles, CA, 90095, USA, 3Department of Molecular and Medical Pharmacology, University of California, Los
Angeles, CA 90095, USA.
Bacteria develop a broad range of phage resistancemechanisms, such as prevention of phage adsorption and
CRISPR/Cas system, to survive phage predation. In this study, Pseudomonas aeruginosa PA1 strain was
infected with lytic phage PaP1, and phage-resistant mutants were selected. A high percentage (,30%) of
these mutants displayed red pigmentation phenotype (Red mutant). Through comparative genomic
analysis, oneRedmutant PA1rwas found to have a 219.6 kb genomic fragment deletion, which contains two
key genes hmgA and galU related to the observed phenotypes. Deletion of hmgA resulted in the
accumulation of a red compound homogentisic acid; while A galU mutant is devoid of O-antigen, which is
required for phage adsorption. Intriguingly, while the loss of galU conferred phage resistance, it
significantly attenuated PA1r in a mouse infection experiment. Our study revealed a novel phage resistance
mechanism via chromosomal DNA deletion in P. aeruginosa.
B
acteriophages and their bacterial hosts are constantly engaged in evolutionary competition1–3. On the one
hand, bacteria employ a wide range of resistance mechanisms, including prevention of phage adsorption
and phage DNA entry, digestion of phage nucleic acids, and development of abortive infection and
CRISPR/Cas systems to evade phage infection or survive phage killing1,4–7. On the other hand, bacteriophages
are capable of rapid adaptive responses to evolutionary changes in their hosts2. Adsorption of phages into
bacterial hosts by specific interactions between phage proteins and receptors on the bacterial cell surface is the
initial step of infection8,9. Several receptors, including lipopolysaccharides (LPS), capsular polysaccharides, fla-
gella, and outer membrane proteins, have been reported5,8,9. As a defensive strategy, bacteria canmodify these cell
surface receptors and produce extracellular matrix or competitive inhibitors to prevent phage absorption1. As a
counter-defensive measure, phages are able to modify their receptor-binding proteins, such as tail fibers, to
achieve infection and kill the resistant bacterium10,11. For example, Pseudomonas fluorescens SBW25 has coe-
volved with its lytic phage phi2 for over 300 bacterial generations. This co-evolution is probably due to the
continuous modification of bacterial receptors and phage receptor-binding proteins3,12.
P. aeruginosa is an important Gram-negative opportunistic pathogen that causes serious infections in cystic
fibrosis patients, cancer patients, and other immunocompromised individuals13,14. The bacterium remains one of
the leading pathogens found in most medical centers, partly because of its ability to develop resistance to
conventional antimicrobials. Bacteriophages are a group of viruses that are able to infect and kill bacteria15–17;
they have long been proposed as promising alternatives to conventional antibiotics for treating bacterial infec-
tions. Given increasing levels of drug resistance in a variety of pathogens and the shortage of new antimicrobials,
phage research, particularly phage therapy, has recently gained intense research interest18–20. Thus, efforts to
exploit the application of phage therapy in the treatment of bacterial infections have steadily grown. Phage
resistance, an essential survival strategy of bacteria, is an important aspect of bacterial-phage interactions and
poses serious obstacles in the application of phage therapy21. Therefore, a better understanding of the mechanism
of phage-resistance is critical in helping design successful phage-therapy strategies to treat/prevent bacterial
diseases, including P. aeruginosa-related infections4,22.
We have recently isolated and sequenced three P. aeruginosa phages to explore their biological properties and
interaction with host bacteria11,23,24. In this study, using one of the lytic phages (PaP1) and a clinical isolate of P.
aeruginosa strain (PA123), we identified a novel phage resistance mechanism by chromosomal DNA deletion.
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Results
PaP1 infection of P. aeruginosa resulted in red-pigment pro-
ducing, phage-resistant mutants (Red mutants). To investigate
phage resistance mechanism in P. aeruginosa, wild-type strain PA1
was infectedwith phage PaP1 (MOI5 1000) and screened for phage-
resistant mutants, which could be consistently recovered in high
frequency (3.02 6 0.85 *1025) (Fig. 1A). Interestingly, a high
percentage (31% 6 13.2%) of the mutants produced red pigment,
and two coupled phenotypes can be stably maintained, indicating
geneticmutations. One Redmutant, PA1r, was randomly selected for
further analysis, and its PaP1 resistance, as well as red-pigment
producing phenotypes, was confirmed by dot assay on an agar
plate (Fig. 1B).
Comparative genomic analysis revealed a 219.6 kb genomic frag-
ment deletion in PA1r. To identify the mutation(s) in PA1r that
might confer PaP1 resistance, as well as red-pigment producing
phenotypes, the genomes of both PA1 and PA1r were sequenced
(GenBank: PA1: CP004054, PA1r: CP004055) and subjected to
comparative genomic analysis. A 219,572 bp genomic fragment
deletion (6,217,866 to 6,437,440) in PA1r compared with PA1
(Fig. 2A) was observed. Sequences flanking the end points are
shown in Fig. 2A.
The deletion in PA1r was confirmed by pulsed-field gel electro-
phoresis (PFGE) (Fig. 2B) and polymerase chain reaction (PCR)
(Fig. 2C, Primer sets inMaterials andMethods). The precise deletion
site in PA1r was verified by PCR (Fig. 2D, Primer sets 6U/6D).
Results showed that the deleted fragment in PA1r was flanked by
gene cupA3 and PALES_33891 compared with another type of strain
LESB5825.
Loss of hmgA gene as a result of genomic fragment deletion is
responsible for red pigment production in PA1r. Bioinformatic
analysis revealed that the deleted 219.6 kb genomic fragment
Figure 1 | A subpopulation of phage resistant P. aeruginosa mutants produces red pigment. (A): Red mutants were detected among other white phage
resistant mutants. (B): Dot assay on agar plate shows that PA1r is phage resistant and produces red pigment.
Figure 2 | Genomic fragment deletion in phage-resistant strain PA1r. (A): Diagram of P. aeruginosa genomes. 219.6 kb deleted fragment in PA1r is
shown by dotted line. (B): PFGE of SpeI-digested genomic DNA from PA1 and PA1r. (C): PCR analysis of PA1 and PA1r. Positions of primers used for
PCR analysis are indicated in Fig. A. (D): PCR analysis of the deletion site in PA1r.
www.nature.com/scientificreports
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contains 192 genes (Fig. S1), including hmgA, a gene encoding the
enzyme homogentisate-1, 2-dioxygenase that converts homogentisic
acid into 4-maleylacetoacetate. Inactivation of this gene results in the
accumulation of homogentisic acid, which gives the cell a red
pigmentation phenotype26,27.
An hmgA insertional deletion mutant (PA1DhmgA) was gener-
ated. PA1DhmgA produced red pigment but still retained sensitivity
to phage PaP1 (Fig. 3), and complementation of hmgA gene in PA1r
background did not restore the phage-resistant phenotype (Fig. 3).
These results suggest that hmgA gene deletion does not confer PaP1
phage resistance.
Transposonmutagenesis revealed the involvement of PA1 lipopo-
lysaccharides (LPS) in phage PaP1 infection.A random transposon
mutant library of P. aeruginosa PA1 was infected with phage PaP1 to
identify genes in P. aeruginosa that are essential for phage PaP1
infection. Two phage-resistant mutants (B10 and T2) (Table 1)
were isolated and transposon insertion sites were determined by a
two-step semi-degenerate PCR28. The mutation in B10 and T2 was
mapped to genes PA0938 (wzz2) and PA5001, respectively, both of
which have been shown to be involved in LPS biosynthesis29. Given
that LPS often serve as phage-receptors in a variety of bacterial
species8,30, our data suggested that PaP1 could potentially recognize
PA1 LPS as receptors and initiate the infection process.
PA1r carries defective LPS and can prevent phage adsorption.
Agglutination test31 was performed with wild-type PA1 and PA1r
strains to determine whether the resistance of PA1r to PaP1 infection
was due to its defect in LPS biosynthesis. Results showed that PA1
remained as single cells, whereas PA1r tended to form cell clumps
(Fig. 4A), suggesting that PA1r carries defective LPS.
Adsorption assays also revealed a significant reduction in phage
adsorption to PA1r compared with wild-type PA1 strain (Fig. 4B).
The result of the binding assay was further confirmed by transmis-
sion electron microscope data. After 3 min co-incubation, a signifi-
cantly higher number of phage PaP1 particles can be seen attached to
the surface of PA1 cell than those binding to PA1r (Fig. 4C).
Loss of galU in PA1r is responsible for phage resistance. Aggluti-
nation assay and phage adsorption data suggested that a possible
defect in LPS biosynthesis might confer PaP1 phage resistance in
PA1r. A detailed bioinformatic analysis revealed within the deleted
fragment the presence of galU, a gene involved in LPS biosynthesis.
This gene encodes UDP-D-glucose pyrophosphorylase which con-
verts Glc-1-phosphate to UDP-D-Glc, which is the predominant su-
gar in the outer core of oligosaccharides. A galUmutant is devoid of
O-antigen and synthesizes a defective LPS core32–34. Thus, a galU
insertional deletion mutant (PA1 DgalU) was constructed. PA1DgalU
showed a defect in LPS and was resistant to phage PaP1 infection.
Moreover, galU was complemented into PA1r resulting in PA1r:
galU, which was sensitive again toward this phage (Fig. 3).
High-frequency genomic fragment deletion is not site-specific.
Three more Red mutants were randomly chosen and subjected to
PCR and PFGE for further analysis to determine if Redmutants carry
the same deletion. All three Red mutants (PA1R-37, PA1R-57, and
PA1R-61) revealed genomic deletions with sizes similar to PA1r
(Fig. 5). The deleted fragments ranged from approximately 200 kb
to 300 kb, encompassing the region containing both galU and hmgA
genes. However, the exact deletion sites among these mutants were
different.
PA1r is significantly attenuated in a mouse infection model. Our
data suggested that PA1r acquired phage resistance by deleting a
large genomic fragment that contains galU gene essential for LPS
biosynthesis. Although the defect in LPS confers resistance to phage
infection, this defect might reduce the mutant’s ability to infect a
host, because LPS is an important virulent factor in Gram-negative
bacterial pathogens, including P. aeruginosa. To test this hypothesis,
PA1r was used to infect mice intraperitoneally, and their survival was
monitored. All eight mice died within 24 h after infection with either
PA1 or PA1r:galU, whereas all eight mice survived the infection with
PA1r or PA1DgalU (Fig. 6).
Red mutants are likely to arise spontaneously before phage
infection. Fluctuation test was performed to demonstrate whether
the genomic fragment deletion is induced after phage infection. As is
shown in Figure 7, the number of red colonies on each plate varied
drastically, from 2 to 45 colonies, in Group A; while the variation
from group B is very small. This implies that deletionmutation arises
before phage infection.
Discussion
In this study, a series of phage-resistant P. aeruginosa mutants were
isolated, and almost 30% of these mutants produced red pigment.
However, by reviewing the phage resistance mechanisms1,2,35, no
gene has been related to pigment production. Comparative genomic
analysis revealed a 219.6 kb genomic fragment deletion in resistant
mutant PA1r, including hmgA, which has been demonstrated to be
associated with red pigment production (Fig. 3). However, the loss of
hmgA could not confer phage resistance to PA1 (Fig. 3).
We further demonstrated that the loss of galU, a key gene involved
in LPS biosynthesis, which is 19 kb in front of hmgA, confers phage
resistance to PA1r by preventing phage adsorption because LPS is the
likely receptor of PaP1 (Fig. 3). Adsorption to the receptor is the
initial step for phage infection. Several phage receptors in Gram-
negative bacteria, such as LPS, capsular polysaccharides, flagella,
and outer membrane proteins5, have been identified. Mutation of
the receptor is a common strategy for bacteria to avoid phage pre-
dation5,35. We used an agglutination assay to show that PA1r carried
defective LPS (Fig. 4A). Given that the core oligosaccharide is abund-
ant with negatively charged groups of 2-keto-3-deoxyoctulosonic
acid and phosphate, strains that lack O polysaccharide will expose
core oligosaccharide to the cell surface and cover up the negative
Figure 3 | Dot assay on agar plate. 1 ml PA1DhmgA, PA1r: hmgA,
PA1DgalU, PA1r: galU and PA1r were spotted on a LB plate alone ormixed
with 2 ml 108 pfu/ml PaP1, and incubated at 37uC for 24 h.
Table 1 | Transposon mutants resistant to phage PaP1 infection
Transposon mutant Gene mutated Function encoded Pathway involved
B10 PA0938(wzz2) Involved in O-antigen chain length determination LPS biosynthesis[29]
T2 PA5001 putative glycosyl/glucosyltransferase LPS biosynthesis[29]
www.nature.com/scientificreports
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charges. Therefore, LPS negative strains could be agglutinated by
high salt concentrations31.
One of the major concerns regarding phage therapy is that phage-
resistant mutants might result in the failure of phage therapy21.
According to our experiment, phage-resistant bacteria are swift to
emerge, and the frequency is much higher than those of drug-resist-
ant mutants. However, phage-resistant mutant PA1r has defective
LPS, and LPS is a major virulence factor in P. aeruginosa. Thus, LPS
minus mutant PA1r is significantly attenuated in the mouse model
(Fig. 6). The trade-off between phage resistance and fitness, such as
growth rate or virulence, has also been reported in other phage-host
experiments36, which suggests an advantage of phage therapy.
From a genetic perspective, the genomic fragment deletion as a
response to phage predation and the underlyingmechanism of phage
resistance have not been reported. Phage resistance is often acquired
by mutations1, DNA fragment insertion (CRISPR)37, or genomic
rearrangements6. Our study demonstrated that bacteria could defend
phage infection by deleting their own genomic fragment containing
Figure 4 | PA1r is LPS negative and prevents phage adsorption. (A): Agglutination test: PA1 remains single cells in 4% NaCl, but LPS negative
bacteria PA1r are agglutinated. (B): Adsorption Assay of Bacteriophage PaP1 to P. aeruginosa PA1, PA1r, PA1DgalU and PA1r:galU. Phage adsorption to
PA1 and PA1r were significantly different (Tukey’s Multiple Comparison Test: P, 0.05). (C): Transmission electronmicrograph shows that phage PaP1
binds to PA1 but not to PA1r.
Figure 5 | Genetic analysis of different phage-resistant Red mutants. (A): PCR analysis of different resistant mutants. Primers used are indicated in
Fig. 6C. (B): PFGE of SpeI-digested P. aeruginosa genomic DNA from different mutants. (C): Genomic diagram of PA1 and different mutant strains.
www.nature.com/scientificreports
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galU gene essential for phage infection. The two main causes of
genomic fragment deletion are spontaneous and site-specific.
Spontaneous deletion is caused by the dysfunction of DNA replica-
tion and repair system38. In this case, the deletion site is random and
the deletion rate is quite low. For example, Tanji et al. isolated a
phage-resistant Escherichia coli strain D198, which revealed a
209.4 kbp spontaneous deletion39. However, this deletion was spon-
taneous and not repeatable. In an evolution experiment with E. coli
after 20,000 generations, only seven deletions were found, ranging
from 1 bp to 23,293 bp40. In Salmonella enterica, the DNA loss rate
was estimated to be 0.05 bp per chromosome per generation41. Sanna
et al. estimated the apparent deletion rate in S. entericawith chromo-
somal variation ranging from 0.5 3 1029 to 2.2 3 1028/cell/genera-
tion42. Another experiment with P. aeruginosa also revealed random
fragment deletion, but the deletion sites were unspecific and the
frequency was quite low43.
By contrast, site-specific deletion ismediated by prophage or other
mobile genetic elements44. These large DNA fragments are often
genomic islands acquired by horizontal gene transfer and could be
excised and integrated at a specific site mediated by integrase and
other enzymes. This kind of deletion may usually occur at a high
frequency. For example, an 89 kbp pathogenicity island in
Streptococcus suis, which is flanked by a 15 bp direct repeat, could
be excised from the genome with a certain frequency (,3.2 3 104)45.
In our experiments, the deletion events showed three clear novel
features: high frequency (1026), large genomic fragment deletions
(200 kb to 300 kb), and no site-specificity. Thus, this deletion is
neither site-specific nor spontaneous. Interestingly, smaller deletions
are certainly favored in bacteria because the cost would be smaller,
although the deletions in our experiment ranged from 200 kb to
300 kb. However, by reviewing the genes within the deleted region,
none of the genes, including toxin genes, are obviously deleterious
(Fig. S1). Therefore, this might be a novel deletionmechanism, and it
is currently investigated in our laboratory.
Another interesting issue is whether the observed deletion was
induced by phage infection or occurred before phage predation.
The fluctuation test46 is a classical experiment to prove that phage
resistant mutants arise before phage infection. If genomic fragment
deletion was caused by an induced activation in bacteria, then each
plate should contain roughly the same number of red colonies,
because the deletion frequency should be consistent in the bacteria
population. However, we found that the number of red colonies on
each plate varied drastically, from 2 to 45 colonies in Group A; while
the variation from group B is very small (Figure 7). This implies that
deletion mutation arises before phage infection. What’s more, the
replication time of bacterium PA1 is 40 to 60 min at log phase
(Figure S2), and the infection cycle of phage pap1 is about 40 min.
Thus, within 40 min, the bacterium is unlikely to be able to delete its
genomic fragment and losses LPS, because phage already killed bac-
teria before they replicate. Thus, it seems that the deletion mutants
might have already existed in the bacterial population before phage
infection.
Figure 6 | Phage resistant mutant PA1r is attenuated due to the loss of
galU. Survival wasmonitored in BALB/cmice at 24 h after challenged with
3*107 CFUwild type PA1, phage resistantmutant PA1r, galUmutant, PA1
DgalU or complementary strain PA1r:galU. Three independent replicates
were performed, results were the same.
Figure 7 | Red mutants arise before phage infection. Diagram of fluctuation test is shown in the figure, and the numbers of red colonies are listed
in the table. The numbers in Group A varied drastically, and the difference between group A and B is significant. (Student’s t test, P, 0.05). Results from
three independent replicates were similar, and this table presented the data from one replication.
www.nature.com/scientificreports
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The more intriguing question is why bacteria delete such a big
fragment of their genome in the absence of phage. It is likely that
phage resistant mutants were selected before phage treatment due to
as-yet-unknown fitness benefits. In an effort to determine whether
the selection could be due to mutants’ growth advantage in culture
medium, we compared the growth rate of PA1 and the deletion
mutant PA1r. Compared to PA1 wildtype, PA1r displayed growth
defect. (Figure S2). Furthermore, in a head-to-head competition
experiment, PA1r was outcompeted by PA1(Figure S3). The fact that
deletion mutants did not rise to a high frequency in the absence of
phage could be due to the growth cost incurred by this deletion. This
pleiotropic effect has also been reported in other phage resistant
bacteria47,48. For example, phage resistant mutant of Pseudomonas
fluorescens SBW25 was found to be less competitive when competing
with wide type bacteria48. Thus, the unknown fitness of the deletion
mutants before phage infection still needs further investigation in
this system. In summary, we reported a novel phage resistancemech-
anism in which P. aeruginosa evades phage infection by genomic
fragment deletion, a finding that could provide valuable insight into
phage therapy.
Methods
Bacteria and bacteriophage growth conditions. Phages and hosts used in this study
are listed in Table 2. P. aeruginosa and lytic phage PaP1 were stocked in our
laboratory. P. aeruginosa strains were grown on Luria-Bertani (LB) agar plates or in
LB broth with aeration at 37uC. When required, ampicillin, gentamicin, or
tetracycline were used. Their concentrations in different media are described below.
Selection for phage-resistant mutants. P. aeruginosa PA1 was grown at 37uC in LB
brothwith aeration.When the bacterial culture reachedOD600 of 0.2, 10 ml of culture
(approximately 13 106 cfu) wasmixed with 100 ml and 1010 pfu/ml phage PaP1. The
phage-infected culture was incubated at 4uC for 5 min and spread to one LB agar
plate. Plates were then grown at 37uC for 24 h. Phage sensitivity of the isolated
colonies were tested as previously described11. Briefly, 3 ml of 0.8% soft agar was
mixed with 50 ml overnight culture of bacteria and was layered onto bottom agar.
Finally, 10 ml of phages were deposited on the agar and incubated overnight at 37uC.
DNAextraction.GenomicDNA from P. aeruginosawild-type strain PA1 and phage-
resistant mutant PA1r were extracted using UNlQ-10 Column Bacterial Genomic
DNA Isolation Kit (SK1202; Sangong Biotech, Shanghai) according to the
manufacturer’s instructions. The quality and quantity of extracted DNA were
measured using spectrophotometry. Extracted DNA with a concentration of up to
500 ng/ml was used for the whole genome sequencing and PCR verification.
High-throughput genome sequencing. The complete genomes of the wild-type
strain PA1 and the PaP1-resistant mutant PA1r were sequenced using Solexa to a
depth of 2003 (median coverage 1613), according to the manufacturer’s protocols.
The reference genome of P. aeruginosa strain LESB58 (GenBank accessions:
NC_011770) was downloaded from NCBI and used for mapping the short
sequencing reads produced by the Illumina Genome Analyzer. The sequencing reads
of each isolate were mapped separately to their corresponding reference genome.
Verification of genomic fragment deletion by PCR. Primer sets (1U/1D, 2U/2D,
3U/3D, 4U/4D, and 5U/5D; Table 3) were designed to amplify five different regions
within the 219.6 kb fragment. Primer set 6U/6D (Table 3) was used to detect the
Table 2 | Bacterial strains, plasmids, and phage used in this study
Bacterial strain or plasmid Relevant feature(s)a Reference or source
P. aeruginosa Strains
PA1 Wide type strain for phage PaP1 [23]
PA1r Phage resistant mutant This study
PA1R-37 Phage resistant mutant This study
PA1R-57 Phage resistant mutant This study
PA1R-61 Phage resistant mutant This study
PA1DhmgA Insertional deletion of hmgA This study
PA1DgalU Insertional deletion of galU This study
PA1r: hmgA Complementation of hmgA This study
PA1r: galU Complementation of galU This study
E.coli strains
S17-1 (l pir) Conjugative donor strain [51]
SM10pir Conjugative donor strain [28]
Bacteriophage
PaP1 Lytic phage [23]
Plasmid
pUCP24 4.036-kp pUC18-based broad-host-range vector, Gmr [52]
pEX18Tc Gene replacement vector, Tcr [51]
pCM639 ISphoA | hah-Tc delivery plasmid [28]
pucp-galU Broad-host-range vector containing galU, Gmr This study
pucp-hmgA Broad-host-range vector containing hmgA, Gmr This study
pEX –galU galU deletion vector, Tcr This study
pEX -hmgA hmgA deletion vector, Tcr This study
Abbreviations: Gmr, gentamicin resistance. Tcr, tetracycline resistance.
Table 3 | Primers for detecting the deletion sites in phage resistant
mutants
Primer name Sequence
1U GCGGAGGCGAAGAAATGAAAGC
1D TTGACAGCGAACGGGTGAAACG
2U AGGGTCAGGTTCATAGCGGTCTCC
2D CGTCCAGTCTTCCTTGCGTTCC
3U GCCTGACAGCCAAGACGAGGAACA
3D GCCGAGCACGCAGGAAATGTAGC
4U CGCGTACAGGCTCATCAGCAACCC
4D TTCACCTTCGCCATCGCCATCA
5U GCCCACCGAATCTTCATAACACCA
5D AGGCGAACCAGAGCACCGTCAG
6U CTGGGAATGGATGACGAGACCTAC
6D GGATCGAGTGAGATCGGGTTGTA
7U GCAACAGGCGACCGATGAGGA
7D GGCGATGCCCGACAGCCAAGA
8U GCCACCAGTCCAACTACACCTA
8D ACGGCACGCTGAAGCTCGATAC
9U ATGATCAAGAAATGTCTTTTCCCG
9D TCAGTGAGCCTTGCCGGTCTTGT
10U AATTTAGAGCTGTCGCCTGTTTA
10D GATTGCCTATGCCAGTTAGTTTA
11U ACTATCTGAGCACGCAGAAGC
11D CGGTAGGTCTCGTCATCCATT
www.nature.com/scientificreports
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precise deletion site in PA1r. Primer sets (7U/7D, 8U/8D, 9U/9D, 10U/10D, and 11U/
11D; Table 3) were designed to detect different deletion sites in different Redmutants.
Their locations are indicated in Figs. 2A and 5A.
PFGE. PFGE was performed as previously described49 with the following
modifications. After digestion of the genomic DNA with SpeI, PFGE was performed
at 14uC with CHEF MAPPER XA (Bio-Rad) at 200 V with switch times that ranged
from 5 s to 52 s for 18 h.
Transposon mutagenesis. Transposon mutagenesis was performed as previously
described28 with the following modifications. After mixing P. aeruginosa PA1 with E.
coli strain SM10pir/pCM639 for 2 h, the cells were collected and resuspended in 1 ml
of LB. Bacterial cells were then incubated with a 30-fold excess of the phage PaP1 for
20 min at 37uC and plated on LB medium containing tetracycline (65 mg/ml) and
chloramphenicol (10 mg/ml) for the inhibition of the donor strain. The insertion of
the transposon was identified by a two-stage semi-degenerate PCR and sequencing as
described previously28.
Electron microscopy. Phage PaP1 and bacterial strain PA1 or PA1r were co-
incubated for 3 min and placed on copper screen for 10 min before being negatively
stained with 2% phosphotungstic acid (pH 4.8) for 1 min50. The samples were then
scanned under TECNAI 10 electronmicroscope (Philips, The Netherlands) at 80 kV.
Agglutination test. LPS minus bacteria were agglutinated by high salt
concentrations31. This procedure offers a simple way to distinguish LPS defective
bacteria. Bacteria pellets from centrifuged cultures were resuspended in 4% NaCl for
5 min. Cells were then examined by microscopy. The cells of LPS defective strains
were clumped together, whereas the LPS positive strains remained as single cells.
Bacteriophage adsorption assay. Bacteriophage adsorption assays were performed
to determine whether insensitivity to bacteriophage was caused by receptor
mutation11. Overnight culture of bacteria was collected by centrifugation at 13,000 3
g for 1 min, and the cell pellet was washed with LB and resuspended to a final
concentration of 109 cfu/ml in LB. Bacteriophage was added at a concentration of
105 pfu/ml to the bacterial suspension and incubated at 37uC with 150 rpm shaking
under aerobic condition for 3 min. The samples were then filtered through a 0.2 mm
filter, and phage titer was immediately determined by plaque assay. Percentage
adsorption of the phage was calculated using the following equation: Percentage
adsorption 5 [(initial titer 2 residual titer in the supernatant)/initial titer] 3 100.
Error bars represent the standard deviation of the three independent experiments.
Construction of galU and hmgA of P. aeruginosa mutants. P. aeruginosa galU
insertional mutant was constructed by a described previously procedure51. With the
use of PA1 genomic DNA as a template, a 598 bp fragment of galU was PCR-
amplified with primer set q-GalU-U2 (forward: 59-AAGCTT AAGGAAATGCTG-
CCGGTGGTGA-39) and q-GalU-D2 (reverse 59-CTATTCTAGA TTGCCCGG-
TTCAGTCTGCTCGA-39). PCR products were gel-purified and ligated into T vector
(pMDH19-T Simple vector, TaKaRa Code:D104A), resulting in pT-Q-galU.
Fragment containing galU gene on the plasmid pT-Q-galU was cut out with XbalI/
Hind III, and ligated into the XbaI/Hind III digested pEX18Tc, resulting in pEX -
galU. Then, pEX -galU was transformed into E. coli strain S17-1 and conjugated into
PA1 to generate galU insertional mutant via single crossover. The hmgA gene was
knocked out as described above with the primers (forward 59-tcatAAGCTTCGA-
GCAGCCCACCGACTTCCT-39) and (reverse 59-ctatTCTAGA GACCGTGCC-
GATGGTGTTGAA-39).
Complementation of PA1r with galU or hmgA gene. The galU gene was PCR-
amplified using forward (59-GGATCCTATGATCAAGAAATGTCTTTTCCCG-39)
and reverse primer (59-CTGCAGTCAGTGAGCCTTGCCGGTCTTGT-39), and
cloned into T vector (TaKaRa) resulting in pT-galU. The galU gene was then released
from plasmid pT-galU via digestion with BamHI and PstI, and cloned into the same
sites on pUCP2452 to generate pucp-galU. Then, pucp-galU was electroporated into
strain PA1r to create PA1r:galU strains. The hmgA was complemented into PA1r
using the same method with the primers forward hmgA-u (59-
ggatcctATGAACCTCGACTCCACTGCCC-39), and reverse hmgA-d (59-
CTGCAGTTATCTCCGTTGCGGGTTGAAG-39).
Mouse infection experiment. The Animal Research Ethics Committee of Third
Military Medical University approved this mouse protocol. The animal experiment
was performed in accordance with the Guidelines for the Care and Use of Laboratory
Animals at Third Military Medical University. Bacteria were grown in 10 ml LB
medium at 37uC until the early stationary phase. Cells were collected by
centrifugation at 10,0003 g for 1 min. The cell pellet was washed and resuspended in
saline to a final concentration of 3 3 107 cfu/ml. Each strain (1 ml) was injected
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